Introduction

DPH1 encodes a component of a multi-protein complex—formed together with DPH2, DPH3, DPH4, and DPH5—for diphthamide biosynthesis [1, 2]. To date, at least two DPH1 mutations have been reported, which cause intellectual disability and dysmorphic features [3, 4]. However, the pathogenetic mechanisms by which the DPH1 mutations produce the clinical phenotype are unknown. Here, we report the identification of a consanguineous family with two siblings both showing dysmorphic features and developmental delay caused by a novel homozygous DPH1 mutation, identified by wholeexome sequencing (WES). We also discuss how the genetic mutation might contribute to the clinical features in this family.

Materials and methods

Samples

Peripheral blood samples were collected from two affected siblings and their consanguineous parents (Fig. 1a) after a written informed consent was obtained. Genomic DNA was extracted from the peripheral blood leukocytes with a QIAamp DNA Mini Kit (Qiagen, Hilden, Germany). The study protocol was approved by the institutional review board of Yokohama City University School of Medicine.

Fig. 1
figure 1

Genetic analysis of the pedigree. a Pedigree. The left half of each symbol represents phenotypes associated with DPH1 mutations, and the right half shows craniosynostosis caused by the FREM1 mutation. b Brain CT of Patient 1 at the age of 4 years. Cephalic index is calculated as 85.6%. Possible agenesis of the corpus callosum is seen. c Chromatograms of DPH1 (left) and FREM1 mutations (right). d Schematic illustration of DPH1 cDNA (upper panel) and DPH1 protein (lower panel). The red box shows the diphthamide synthase domain. e Schematic illustration of FREM1 cDNA (upper panel) and FREM1 protein (lower panel). Boxes within the arrows show the following domains: blue, transmembrane region; yellow, cadherin-3; orange, calx-beta; green, C-type lectin or carbohydrate-recognition domain. All functional domains were predicted by SMART (http://smart.embl-heidelberg.de/smart/). Previously reported mutations are shown in black and mutations detected in this study are shown in red (c, d). WT wild type, mut mutant allele, DPH1 diphthamide biosynthesis 1, FREM1 FRAS1-related extracellular matrix 1

Genetic analysis

WES was performed as reported previously [5]. In brief, 3 μg of genomic DNA was sheared and captured using a SureSelect Human All Exon V5 kit (Agilent Technologies, Santa Clara, CA) and sequenced on a HiSeq2000 system (Illumina, San Diego, CA) with 101-bp paired-end reads. Based on the autosomal recessive model, variants with minor allele frequencies of >0.005 in the Exome Aggregation Consortium (ExAC), the National Heart Lung and Blood Institute Exome Sequencing Project (NHLBI-ESP 6500), or Human Genetic Variation Database (HGVD) and variants that were found in the in-house exome data of five or more individuals (from a total of 575 Japanese subjects) were excluded from further analysis. In addition, variants were filtered based on an autosomal dominant model; variants with allele frequencies of >0 in any of the public databases listed above and in-house data were excluded (Supplemental Table 1). Variants on chromosome X were also filtered based on an X-linked recessive model (Supplemental Table 1). Non-excluded variants were further validated by Sanger sequencing on an ABI 3500 Genetic analyzer (Applied Biosystems, Foster City, CA) and analyzed with Sequencher software (Gene Codes, Madison, WI). Homozygous regions were investigated using HomozygosityMapper (http://www.homozygositymapper.org/) [6].

Results

Proband (II-2) (Fig. 1a) was a 10-year-old Iranian boy born as the second child to healthy consanguineous parents. His elder brother had hypotonia, heart disease, and gastroesophageal reflux. He died at 6 months, and the cause of death was recorded as sudden infant death syndrome. In the proband, brachycephaly and a cleft palate were noticed at birth, and agenesis of the corpus callosum (ACC) and cerebellar vermis hypoplasia were found by an MRI at the age of 1 year. His brain CT at 4 years showed brachycephaly (cephalic index of 85.6%) as well as possible ACC (Fig. 1b). He presented with sparse and thin hair, distinctive features (widely spaced eyes with scleral pigmentation, downslanted palpebral fissures, epicanthal folds, depressed nasal bridge, low-set ears, and widely spaced teeth), a bilateral single simian crease, short stature (120 cm, −3 SD), and kyphoscoliosis. His IQ was 35–49 at the age of 10 years. The first seizure (tonic, generalized) occurred at 5 months, and phenobarbital and sodium valproate were prescribed until the age of 8 years. His karyotype was normal. His kidneys were normal by ultrasound examination.

His 4-year-old sister (II-3) (Fig. 1a) showed similar clinical features (developmental delay, brachycephaly, sparse hair and eyebrows, widely spaced eyes with scleral pigmentation, downslanted palpebral fissures, epicanthal folds, depressed nasal bridge, low-set ears, widely spaced teeth, and short stature) with some differences (details are described in Table 1). She did not exhibit kyphoscoliosis or seizures, but had an atrial septal defect (ASD), which was surgically repaired at 16 months of age. A recent echocardiogram revealed mild to moderate ASD, residual patent ductus arteriosus with trivial shunt, and mildly dilated right atrium and ventricle. Brain MRI identified ACC and a cystic posterior fossa at 2 years of age. Her karyotype was normal. Her kidneys were normal by ultrasound examination.

Table 1 Clinical features of patients with biallelic DPH1 mutations

To identify the genetic cause of the disease, we performed WES on proband II-2. We first considered the autosomal recessive model and found a homozygous frameshift mutation in DPH1, NM_001383.3: c.1227delG, p.(Ala411Argfs*91), which was confirmed in both affected siblings by Sanger sequencing (Fig. 1c, d). Both parents were heterozygous carriers of the mutation. Homozygosity mapping in the proband (II-2) showed a 0.5-Mb homozygous stretch (chromosome 17: 1,761,593–2,297,571 bp), including DPH1.

We also examined other pathogenic variants associated with the clinical features regardless of the inheritance models. Sanger sequencing identified a heterozygous nonsense mutation in FREM1, NM_144966.5: c.4312C>T, p.(Arg1438*) in both affected siblings and their father (Fig. 1c, e). No other variants were detected.

Discussion

We identified a novel homozygous mutation in DPH1: c.1227delG, p.(Ala411Argfs*91). To date, only two DPH1 mutations in eight individuals from four families have been reported: c.17T > A p.(Met6Lys) and c.701T > C, p.(Leu234Pro) [3, 4, 7]. Ten individuals, including the two siblings from the present study, with biallelic DPH1 mutations show cardinal clinical features including abnormal skull shape (trigonocephaly, scaphocephaly, or prominent forehead accompanied with metopic ridge), distinctive face (downslanted palpebral fissures, low set ears, depressed nasal bridge, and sparse hair on the scalp, eyelashes, and/or eyebrows), short stature, developmental delay, and intellectual disability (Table 1) [3, 4, 7]. Heart and brain malformations are also frequently observed in individuals with DPH1 mutations. Cardiac and brain anomalies are commonly observed in four individuals with p.Leu234Pro and the current affecting siblings with p.Ala411Argfs*91, but not in individuals with p.Met6Lys (Table 1) [3, 4, 7]. Cranial abnormalities are consistently found in all individuals with biallelic DPH1 mutations, including scaphocephaly and sagittal craniosynostosis (p.Met6Lys) [3], trigonocephaly (p.Leu234Pro) [4, 7], and brachycephaly (p.Ala411Argfs*91 in the current family). Epilepsy in two individuals, including our case (II-2), responded well to treatment [3]. Cleft palates are unique features and no renal diseases are noted in our family (Table 1).

Dph1 knockout mice exhibit developmental and growth delay, immature lung, cleft palate, abnormal neural tube formation in the midbrain, and perinatal or prenatal death [8, 9]. Conditional ablation of Dph1 in neural crest cells results in craniofacial defects with hypoplastic nasal bone, lower jaw, and cleft palate. [8] Cleft palate in Dph1 knockout mice drew our attention, as it is a unique feature in the current family (the homozygous truncation mutation in the family is likely a knockout).

We also found a heterozygous nonsense mutation in FREM1 in both affected siblings and their father. FREM1 encodes an extracellular matrix protein that plays an important role in epidermal differentiation and fusion of midline structures during craniofacial development [10]. Biallelic FREM1 mutations cause Manitoba oculotrichoanal (MOTA) syndrome (MIM #248450) or bifid nose with or without anorectal and renal anomalies (BNAR syndrome; MIM #608980). Heterozygous FREM1 mutations cause trigonocephaly (MIM #614485) with variable severity and incomplete penetrance [11]. Similarly, heterozygous Frem1 knockout mice show altered cranial frontal bone curvature and have a milder phenotype than homozygous mutant mice [11]. Retrospectively, the father’s cranial bones were carefully examined, and only partial synostosis of the metopic suture was recognized. Therefore, there is a possibility that FREM1 may contribute brachycephaly in the siblings. However, since the other phenotype has not been reported in the mutation of FREM1, the single mutated gene (DPH1) is able to explain the cause of the all phenotype of the two siblings.

In conclusion, we found a novel homozygous DPH1 mutation in two affected siblings, which is likely causative for the clinical findings. Only three DPH1 mutations have been described to date, including the current one. Our family provides insight into genotype–phenotype correlations. However, further studies of families with DPH1 mutations are needed to clarify how the genotype translates into phenotype.